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A YAC Mouse Model for Huntington's Disease
with Full-Length Mutant Huntingtin, Cytoplasmic
Toxicity, and Selective Striatal Neurodegeneration
cally beginning in midadulthood and progressing toward
death z18 years from onset (Hayden, 1981; Harper,
1991). The hallmark neuropathological feature of HD is
neuronal loss in the caudate and putamen (Vonsattel et
al., 1985), primarily affecting the medium spiny projec-
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ner seen in patients with the disease. To this end, yeast
artificial chromosomes (YACs) containing human geno-
mic DNA spanning the full-length gene, including all
Summary regulatory elements, were used. The HD clones were
engineered to contain CAG sizes similar to those seen
We have produced yeast artificial chromosome (YAC) in either adult onset (YAC46 containing 46 CAG repeats)
transgenic mice expressing normal (YAC18) and mu- or juvenile onset (YAC72 containing 72 CAG repeats) HD.
tant (YAC46 and YAC72) huntingtin (htt) in a develop- We found that YAC46 and YAC72 mice develop pro-
mental and tissue-specific manner identical to that gressive electrophysiological abnormalities that pre-
observed in Huntington's disease (HD). YAC46 and cede nuclear translocation and aggregation of htt.
YAC72 mice show early electrophysiological abnor- YAC72 mice have behavioral abnormalities, with onset
malities, indicating cytoplasmic dysfunction prior to influenced by the level of mutant protein. A mouse ex-
observed nuclear inclusions or neurodegeneration. By pressing mutant htt with 72 glutamines at higher levels
12 months of age, YAC72 mice have a selective degen-
presented with an early onset behavioral phenotype (z6
eration of medium spiny neurons in the lateral striatum
weeks) and had intranuclear aggregates and neurode-
associated with the translocation of N-terminal htt
generation specifically in the striatum. Other YAC72
fragments to the nucleus. Neurodegeneration can be
mice expressing lower levels of mutant protein had pro-present in the absence of macro- or microaggregates,
gressive electrophysiologic abnormalities at 6 and 10clearly showing that aggregates are not essential to
months, followed by selective striatal neurodegenera-initiation of neuronal death. These mice demonstrate
tion first seen at 12 months of age. No aggregates werethat initial neuronal cytoplasmic toxicity is followed by
visible by light or electron microscopy, clearly indicatingcleavage of htt, nuclear translocation of htt N-terminal
that aggregates are not necessary for initiation of selec-fragments, and selective neurodegeneration.
tive neuronal loss. On the other hand, translocation of
N-terminal fragments of htt into the nucleus is seen,
providing in vivo evidence of cleavage of htt and theIntroduction
toxic gain of function of these fragments, as first pro-
Huntington's disease (HD) is characterized by personal- posed by Goldberg et al. (1996). These mice represent
ity change, involuntary movements, and dementia typi- the first animal model expressing full-length mutant hu-
man htt under the control of its own promoter, providing
insights into the sequential molecular and cellular events7 To whom correspondence should be addressed (e-mail: mrh@
cmmt.ubc.ca). underlying HD.
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Figure 1. Generation of 46 and 72 CAGs in YACs
(A) Homologous recombination was used to introduce 46 and 72 CAG repeats into YACs containing 18 CAG repeats.
(B) Southern blot of YAC72 transgenic founder mice using human HD±specific probe cD70±2. The copy number in founder F2498 is higher
than that of two other full-length founders (2510 and 2511) and human DNA. Founders 2494, 2712, and 2787 are missing this portion of the
YAC. Equal amounts (10 mg) of DNA were loaded per lane.
Results Additionally, in light of the observed electrophysiolog-
ical changes in the hippocampi of YAC46 and YAC72
mice (see below), we confirmed that human htt wasYAC Transgenic Mice
expressed in the hippocampi of YAC transgenic mice byTwo well-characterized YACs (YGA2 and 353G6) con-
Western blot (Figure 2B) and by immunohistochemistrytaining 18 CAG repeats and spanning the entire HD gene
(data not shown). Expression was low in peripheral tis-(Hodgson et al., 1996) were used.
sues, similar to humans.We adopted a previously described strategy using
Mutant htt expression in fibroblast cell lines revealedhomologous recombination in yeast to introduce ex-
htt expression in YAC72 founder 2498 to be approxi-panded CAG repeats (46 and 72) into YACs (Duff et al.,
mately three times that seen in founder 2511 (Figure1994) (Figure 1A). Since YACs are inherently unstable,
2C) and approximately twice that of endogenous levelsand this strategy relies on homologous recombination,
(data not shown). Expression levels in YAC18, YAC46,all clones were extensively screened by Southern analy-
and YAC72 (2511) lines were equivalent, representingsis, PCR, and pulse-field gel electrophoresis.
one-third to one-half of endogenous level expressionSouthern analysis comparing signal intensity with hu-
(Figure 2D).man genomic DNA demonstrated that all YAC46 trans-
genic lines had integrated one to two copies of the YAC
Rescue of Embryonic Lethality(data not shown). Two of the seven lines injected with
We next tested for appropriate developmental regula-YAC72 integrated the complete HD gene (2498 and
tion by assessing whether mice expressing mutant hu-2511). Densitometric scanning showed that founder
man htt (YAC46 or YAC72) could compensate for the2498 had integrated approximately four copies of the
loss of endogenous htt. Targeted disruption of htt resultstransgene (two wild-type), whereas line 2511 integrated
in embryonic lethality at 7.5 days gestation (Duyao etone to two copies (Figure 1B). We were able to establish
al., 1995; Nasir et al., 1995; Zeitlin et al., 1995). Welines from all founder mice with the exceptions of YAC46
crossed the YAC46 and YAC72 lines onto the null back-664 and YAC72 2498, which developed an early neuro-
ground and demonstrated efficient rescue of the em-logical phenotype at 6 weeks of age (see below) and
bryonic lethality. The genotype of the YAC-positivedid not breed.
offspring at the mouse HD locus had the expected Men-
delian 1:2:1 ratio for homozygous, heterozygous, and
Transgene-Derived htt Is Expressed in a Pattern wild-type offspring (35:68:26, respectively). In contrast,
Similar to Endogenous htt cDNA transgenic mice expressing full-length htt with
Both normal and mutant human htt were expressed in 18, 44, and 128 glutamines under the control of the
the same tissues as the endogenous mouse protein, cytomegalovirus promoter failed to rescue the embryo
with highest levels seen in brain and testes (Figure 2A). lethality.
Subcellular localization experiments on cortical tissue These data provide conclusive evidence of appro-
from wild-type and transgenic mice showed that mutant priate developmental expression of mutant htt under
YAC-derived htt primarily localized to the cytosolic and the control of the endogenous promoter and show that
membrane-associated fractions (data not shown), simi- expansion of the polyglutamine tract does not disrupt
normal function of htt in mammalian development.lar to human htt (DiFiglia et al., 1995).
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Figure 2. Human htt Expression in YAC Transgenic Mice Parallels that Seen with Endogenous Mouse htt Expression
(A) The tissue expression patterns of wild-type (wt) and human htt in YAC18 (tg 18), YAC46 (tg 46), and YAC72 (tg 72) mice. Normal and YAC
transgenic proteins (100 mg of total protein from each tissue) were probed with BKP1 (detects murine and human htt) and GHM1 (detects
human htt only). Htt expression levels are highest in cortex, cerebellum, and testes. A longer exposure of the blots indicated murine and
human htt are also expressed at low levels in other tissues tested.
(B) Western blot using human-specific monoclonal antibody GHM1 showing hippocampal expression of human htt in two YAC46 (1749 and
1746) and YAC18 (line 29) mice.
(C) YAC transgenic mice expressing human htt with 72 glutamines have varying levels of expression, depending on the copy number of the
gene. YAC72 founder 2498 expresses human htt at higher levels than founder 2511 using lysates from fibroblast lines assessed using GHMI.
Equal loading was confirmed by equivalent actin levels in each lane.
(D) YAC18, YAC46, and YAC72 transgenic mice express human htt at equivalent levels that are approximately one-third to one-half of
endogenous htt expression.
Motor and Behavioral Analysis YAC72
The weight of the YAC72 mouse (2498) was approxi-Tests were designed to detect behavioral and motor
deficits in wild-type (n 5 7), YAC18 (line 30, n 5 7), and mately half that of her female siblings (16 g versus 29.9
g; n 5 3) when sacrificed at 1 year. YAC72 mice fromYAC46 (line 668, n 5 7; line 1747, n 5 3) mice. Tests
were repeated at 2 month intervals between 3 and 20 line 2511 had body weight similar to controls at all times
assessed.months of age. In addition, observations were made on
the YAC72 mice lines and age-matched controls at 3, Observations of spontaneous behavior were carried
out on the 2498 mouse (Figure 3A) and age-matched5, 7, and 9 months of age. All mice used in this study
were pure FVB/N, eliminating the confounding effects controls (Figure 3B) at the ages of 3, 5, 7, and 9 months.
The 2498 mouse showed obvious circling that was per-of strain differences. YAC18 mice behaved identically
to wild-type mice at all ages tested. sistent and by 9 months was associated with obvious
choreoathetoid movements of the head and neck asYAC46
Weekly observation of mouse behavior and handling of well as gait ataxia. The circling was tight and rapid, with
a full turn being completed in approximately one-thirdthe mice revealed no obvious differences in behavior
compared with wild-type or YAC18 mice up to 20 months of a second (Figure 3C). When held by the tail, 2498
was disoriented and displayed a foot-clasping postureof age. Responsiveness to sensory stimuli, including
auditory cues, olfactory cues, and touch; spontaneous reminiscent of HD exon 1 transgenic mice (Mangiarini
et al., 1996). Additionally, as it was lowered to the benchactivity measurements; motor control; and coordination
were normal. top, unlike wild-type FVB/N mice, it failed to orient itself
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Figure 3. Motor and Behavioral Phenotypes of YAC72 Mice
Behavioral profile of YAC72 mouse 2498 (A) and nontransgenic control mice (B) at 3, 5, and 9 months of age. Tight, rapid circling was the
predominant behavior in founder 2498.
(C) Composite image derived from video footage of mouse 2498's circling behavior. The time taken to complete the circle is approximately
one-third of a second. YAC72 mice (line 2511) develop a late onset circling behavior at 9 months, similar to the 2498 founder. A nontransgenic
age-matched control is shown in the top right-hand corner.
(D) Spontaneous activity measures for wild-type and YAC72 (line 2511) mice tested as independent groups at 3, 7, and 9 months of age.
YAC72 mice show hyperactivity compared with wild-type at 7 and 9 months of age but not at 3 months. Data are expressed as mean activity
over 10 min during dark phase 6 SEM. Mean activity was significantly different from that of wild type at p , 0.03 (asterisk) using the Student's t
test.
upright. In addition, it failed to successfully complete in the hippocampus in YAC transgenic mice and humans
(Gutekunst et al., 1995) (Figure 2B), we examined thethe beam-crossing task.
Mice from the low-expressing YAC72 line (2511) did effect of CAG expansion on synaptic transmission and
plasticity prior to development of a behavioral pheno-not manifest with any obvious behavioral phenotype
until 7 months of age. These mice display a mild hyperki- type. We compared the induction and maintenance of
homosynaptic long-term potentiation (LTP) at the Schaef-netic movement disorder characterized by progressive
spontaneous hyperactivity during the dark phase of fer collateral±CA1 synapses of the hippocampus in con-
trol, YAC46, and YAC72 mice.open field testing (p , 0.03) (Figure 3D). In one mouse,
stereotypical unidirectional circling developed at 8.5 To standardize slices from different groups, we elic-
ited synaptic responses at an intensity that was 50% ofmonths, similar to behavior seen at an earlier age in the
high-expressing YAC72 mouse (Figure 3C). At 9 months, that required to induce a population spike and measured
differences in saturated LTP achieved by repeating te-differences in activity during the dark phase were again
seen in YAC72 mice (Figure 3D). Even though as a group, tanic stimulation five times.
At 6 months, maintenance of LTP at 60 min wasthe mutant mice were more hyperactive compared with
wild-type, there was considerable variability in this result 127% 6 5% for YAC46 mice (line 668, n 5 8), 170% 6
12% for YAC46 mice (line 1747, n 5 4), 221% 6 107%because of the extreme hyperactivity of one mouse with
circling behavior. Excluding this mouse from the mutant for YAC72 mice (line 2511, n 5 4), 179% 6 20% for
group still revealed the significance of the hyperactivity YAC18 mice (n 5 8), and 183% 6 30% for wild-type
(p , 0.05) of the YAC72 mice compared with wild-type. (n 5 10) (not significant) (Figure 4A1). Slices from
6-month-old mice with 72 CAG repeats displayed hyper-
excitability, which manifested itself as epileptiform ac-Electrophysiology
Since hippocampal neuronal loss occurs frequently in tivity at the somatic level, and a very broad excitatory
postsynaptic potential (EPSP) at the distal dendritesHD (Spargo et al., 1993), and mutant htt is expressed
YAC Transgenic Mouse Model for HD
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Figure 4. Effect of CAG Expansion on Synaptic Transmission
Graphs in (A1) and (A3) summarize LTP obtained from 6- and 10-month wild-type (wt), YAC18, YAC46, and YAC72 (line 2511) mice, respectively.
Data are plotted as the mean fEPSP slope 6 SEM (normalized with respect to the 10 min immediately preceding the tetanus) versus time.
Each point is an average of ten traces within 5 min bins. The baseline stimulation intensity was 30%±50% of the maximal response delivered
every 30 s and was constant. Arrows indicate the time at which individual HFS was delivered. The traces are representative field recordings
(averages of ten sweeps) showing the responses 10 min before (baseline) and 60 min after HFS. In (A2), D-AP5 blocks the hyperactivity seen
in the dendritic region of 6-month-old YAC72 (2511) mice. The bar histograms show the area under the fEPSP in the absence and presence
of D-AP5 (25 mM).
(B) Elevated resting calcium levels and lack of calcium influx in response to glutamate in 10-month-old YAC46 mice. Intracellular resting
calcium concentrations are increased in CA1 pyramidal neurons from YAC46 mice (B) (335 6 70 [n 5 6]) compared with wild-type mice (A)
(165 6 12 [n 5 6] [p , 0.05]). Neurons from 10 month YAC46 (line 668) mice did not respond to either 10 mM or 100 mM glutamate (arrows)
in contrast to wild-type mice.
(C) PPF is not altered in YAC46 mice compared with wild-type mice at 6 and 10 months of age.
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Figure 5. N-Terminal htt Aggregates in the YAC72 2498 Mouse
(A) and (B) are light micrographs showing EM48 immunoreactivity in the striatum of a wild-type control and mouse 2498, respectively. EM48
immunoreactivity is obviously more intense in the nuclei of the striatal mouse 2498 than in wild type. EM48 immunoreactivity was very intense
in neuronal nuclei (B), whereas HD549 immmunoreactivity was restricted to the cytoplasm (C). EM48 nuclear immunoreactivity (arrow) did not
occur in VAT- (D), NOSI- (E), or PARV- (F) immunoreactive neurons (arrowheads). Nuclear staining was diffuse and also included small (G)
and large ([H], arrowheads) puncta. By electron microscopy (I), immunogold particles were seen both in the cytoplasm (c) and nucleus (n).
Microaggregates containing more than five particles were found in the nuclei ([I], arrows). At higher magnification, microaggregates appear
to be associated with amorphous, electron-dense material (J). Particles were also found in nuclear pores ([K], arrows). Nuclear pores not
containing immunogold particles are indicated by the arrowheads (K). Scale bar, 30 mm (A±C); 10 mm (D±F); 8 mm (G and H); 3 mm (I); 50 nm
(J); and 100 nm (K).
(Figure 4A1). 2-amino-5-phosphonovalerate (D-AP5) (25 is a crucial factor in the induction of LTP (Malenka et
al., 1988, 1992), was intact in these mice. Calcium tran-uM), which blocks NMDA receptors (Morris et al., 1986)
and under normal conditions has no effect on the fast sients in Fura-2-loaded, acutely dissociated hippocam-
pal CA1 neurons from 10-month-old YAC46 mice consis-synaptic response, blocked the somatic spiking and re-
duced the area under the field EPSP (fEPSP) curve (Fig- tently failed to produce a calcium signal in response to
glutamate application (Figure 4B) in contrast to controls.ure 4A2; 211.75 6 0.189 mV.ms in control slices (n 5
4) and 23.82 6 0.24 mV.ms in D-AP5-treated slices (n 5 Lack of calcium influx can result from downregulation
of NMDA receptors and/or reduced driving force for4) in 6-month-old YAC72 mice. These findings suggest
that in 6-month-old YAC72 mice, the NMDA component calcium. In keeping with these possibilities, resting lev-
els of calcium in neurons from these mutant mice wereis prominent during fast synaptic transmission. Follow-
ing tetanization, most of the slices from YAC72 mice higher (335 6 70 nM [n 5 6]) than those of controls
(165 6 12 nM [n 5 6] [p , 0.05]) (Figure 4B), suggestingdisplayed a greater short-term potentiation (372% 6
124%, p 5 0.20 when compared with wild-type and that the calcium-buffering capacity of mutant neurons
was reduced.YAC18), which progressively declined over time.
By 10 months of age, obvious and significant differ- Elevated intracellular calcium concentration can also
affect presynaptic release mechanisms. To assess pre-ences were seen in both YAC46 and YAC72 mice. In
contrast to wild-type, LTP was not induced in CA1 neu- synaptic efficacy, we investigated the extent of the
paired-pulse facilitation (PPF) in wild-type, YAC18, androns of either line of mice expressing mutant htt (Figure
4A3). The potentiation at 60 min after the fifth tetanus YAC46 mice, which showed no differences from controls
at 6 and 10 months of age (Figure 4C).in slices from 10 month YAC46 mice was 101% 6 25%
(line 668, n 5 6) and 108% 6 12% (line 1746, n 5 6) However, posttetanic potentiation, which is the poten-
tiation seen immediately after tetanic stimulation and iscompared with 199% 6 31% (n 5 6) in wild-type mice
(p , 0.01). High-frequency stimulation (HFS) induced also indicative of presynaptic release mechanisms, was
reduced in 10-month-old YAC46 mice. The normalizeddepression instead of potentiation in 10 month YAC72
mice (Figure 4A3). Lack of LTP induction in mutant slices fEPSP slope immediately after the first HFS was 224% 6
15% in wild-type mice (n 5 6), 167% 6 25% in Trans-was not due to the deterioration of slices, as no change
in the responses within the same slice from the nonteta- genic line 668 (n 5 5), and 102% 6 9% in transgenic
line 1746 (n 5 6) (p , 0.05). These data suggest thatnized control pathway was recorded.
To determine the mechanism underlying the progres- presynaptic terminals in mutant mice, while responding
normally to single stimuli, are not able to sustain neuro-sive loss of LTP in 10 month YAC46 mice, we next inves-
tigated whether glutamate-mediated calcium influx, which transmitter release during high-frequency stimulation.
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Figure 6. Neurodegeneration in Mouse 2498
(A) through (C) are micrographs of 1.5 mm striatal sections from YAC72 2498 (A and B) and YAC18 (C) immunoreacted with EM48 and
counterstained with toluidine blue. In YAC72 2498, many degenerating neurons (stars) are present in the most lateral regions of the striatum
([A], stars) as compared with the more medial regions (B). In YAC18, neurons had a normal appearance, with a regular and well-rounded
nuclear envelope (C). Intense EM48 staining (brown) is seen in a neuronal nucleus (A) in the lateral striatum and in the cytoplasm of neurons
in the medial portion of the striatum (B). Many degenerated neurons contained immunogold particles in their nuclei (n) and cytoplasm (c). In
(D), evidence of degeneration included condensed cytoplasm, swelling of mitochondria (m), vacuolation of Golgi (g), and condensation and
marginization of the heterochromatin ([E], arrows). By electron microscopy, many neurons that did not show frank degenerative signs had
abnormal scalloped nuclear membranes (F). Scale bar, 20 mm (A±C); 3 mm (D); 200 nm (E); and 3 mm (F).
Neuropathology: Nuclear Translocation We and others have proposed that mutant htt is cleaved
in the cytoplasm and that only the N-terminal portion ofof N-Terminal htt
Brains from wild-type (n 5 7), YAC18 (n 5 4), and YAC46 the protein is translocated into the nuclei, where it may
form aggregates (Goldberg et al., 1996; Cooper et al.,(n 5 5) mice were examined at 5, 9, 12, and 20 months
of age. The brains of YAC72 mice were examined only 1998; Hackam et al., 1998; Martindale et al., 1998; Well-
ington et al., 1998). We also performed immunocyto-at 5 (n 5 2), 8 (n 5 2), 10 (n 5 3), and 12 ([n 5 3] [2511],
[n 5 1] [2498]) months. The gross morphology of each chemistry in adjacent sections using EM48 and HD549,
a rat monoclonal antibody that reacts with an internalbrain appeared normal, and a reduction in brain weight
was observed only in YAC72 mouse 2498 (0.41 versus region of htt (amino acids 549±679). Sections stained with
HD549 alone exhibited intense staining of neuronal peri-0.58 g in controls [n 5 3]).
In all mice examined, faint EM48 staining was present karya and dendrites as described previously (Gutekunst
et al., 1995). HD549 immunoreactivity was not detectedin neurons throughout the brain. In contrast, in the 12-
month-old YAC72 mouse (2498), EM48 intensely stained in neuronal nuclei (Figure 5C), suggesting that only
N-terminal fragments of mutant htt (,549 amino acids)many nuclei within neurons in the striatum (Figure 5B),
olfactory tubercle, nucleus accumbens, and fundus stri- translocate to the nuclei.
ati. Small numbers of neurons in the septum and the
granule cell layer of the cerebellar cortex also had nu- Nuclear Staining Is Specific to Medium
Spiny Neuronsclear EM48 immunoreactivity. This intense nuclear stain-
ing was not seen in any other brain regions, including We performed double immunolabeling using EM48 and
antibodies specific for each interneuron population, in-hippocampus, thalamus, and brain stem, nor was it pres-
ent in YAC18 or YAC46 or in wild-type controls (Figure cluding the vesicular acetylcholine transporter (VAT),
which labels cholinergic interneurons; nitric oxide synth-5A). EM48 nuclear staining was more intense in the lat-
eral compared with the medial striatum. ese (NOSI), which labels neurons containing somato-
statin; neuropeptide Y and reduced nicotinamide adenineIn the 12-month-old YAC72 line 2511 (n 5 3), there was
an increased number of EM48-immunoreactive neuronal dinucleotide phosphate± (NADPH-) diaphorase; and parv-
albumin (PARV), which labels a distinct population ofnuclei in the striatum (Figure 7A) and cortex (Figure 7B).
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Figure 7. EM48 Immunoreactivity and Neu-
rodegeneration in the 2511 Line
(A) and (B) are micrographs of representative
striatal sections from a 1-year-old wild-type
control (A) and an age-matched YAC72
mouse from line 2511 (B) stained with EM48.
As compared with the wild-type control,
many more neuronal nuclei were EM48 posi-
tive in the striatum of the YAC72 2511 line. (C)
is an electron micrograph showing a striatal
neuron containg many EM48 immunogold
particles in the nucleus (n), and to a lesser
extent, in the cytoplasm (c). Particles were
found singly or in clusters of no more than
three particles (arrows). (D) is a light micro-
graph of a representative toluidine blue±
stained 1.5 mm semithin section from the lat-
eral portion of the striatum of a YAC72 2511
mouse. Many shrunken and hyperchromatic
degenerating neurons are present (stars). In
addition, neurons with abnormal morphologi-
cal changes, including hyperchromasia, can
also be seen (arrows) adjacent to normal neu-
rons (n). (E) is an electron micrograph show-
ing the morphological features of the normal,
the abnormal (arrow), and the neurodegener-
ated (star) neurons shown in (D) (inset). A de-
generating dendrite can also be seen in the
neuropil (arrow). Scale bar, 60 mm (A and B);
350 nm (C); 20 mm (D); and 10 mm (E).
medium-sized interneurons. None of these interneuron immunogold method and the HD549 antibody, which
does not recognize N terminus aggregates, such clus-populations had nuclear staining by EM48 (Figures 5D±
5F), indicating that in the YAC72 striatum, translocation ters of immunogold particles have not been seen. These
data show that cleavage of htt occurs in the cytoplasmof the N-terminal portion of htt to the nucleus selectively
occurs in medium spiny neurons. and that N-terminal fragments are translocated through
nuclear pores to the nucleus, where they are present
in a small number of macroaggregates visible by lightIdentification of Micro- and Macroaggregates
microscopy or are diffused through the nucleoplasm asIn YAC72 mouse 2498, many striatal nuclei were dif-
microaggregates visible only by electron microscopy.fusely labeled with EM48 and also contained intensely
In the control and low-expressing YAC72 2511 line mice,labeled puncta (Figure 5G) that were 1±2 mm in diameter.
immunogold particles were seen in both the cytoplasmIn the accumbens, some labeled nuclei also contained
and nuclei of neurons. Particles were found mostly sin-one or two larger labeled puncta (Figure 5H) that ranged
gly or in clusters of no more than three particles (Figurefrom 2±5 mm and were found in both intensely and lightly
7C). Clusters of more than three particles were onlystained nuclei. In all stained nuclei, there was a non-
rarely seen in both nucleus and cytoplasm. No macroag-stained region corresponding to the nucleoli by electron
gregates were seen by light microscopy, and microag-microscopy. Similar results were obtained using another
gregates were rare.N-terminal anti-htt antibody raised against the first 17
amino acids of human htt (a gift from Peter Detloff). We
have termed these puncta macroaggregates, since they Neurodegeneration
Neuronal degeneration was assessed by light micros-are large enough to be resolved by light microscopy.
To examine potential htt aggregates, we performed copy in 1.5 mm thick toluidine blue±stained sections
from the striatum, the cortex adjacent to the lateral stria-immunogold electron microscopy using EM48 on sec-
tions containing striatum from YAC72 (2498 and 2511), tum, the hippocampus, and the cerebellum. YAC18 (n 5
5); YAC46 (n 5 10) at 9, 12, and 20 months of age; YAC72YAC18, and FVB/N wild-type mice at 12 months of age.
In YAC72 mouse 2498, immunogold particles were line 2511 at 8 (n 5 4) and 12 (n 5 3) months; and the
YAC72 2498 mouse at 12 months of age were examined.abundant in the nuclei but were also evident at lower
frequency in the cytoplasm (Figure 5I). Within nuclei, Degenerating neurons, only present in the striatum, were
hyperchromatic and shrunken (Figures 6A and 7D). Un-immunogold particles were found singly or in clusters
(Figures 5I and 5J). Individual immunogold particles like striatal neurons, which normally have round nuclei
and rounded cellular outlines, degenerating neurons hadcould also be identified within nuclear pores (Figure 5K).
Most immunogold particles were present singly or in oval or fusiform perikarya and nuclei. The chromatin
within degenerating neurons was also condensed andgroups of two or three. Larger collections of immuno-
gold particles (.5) were visualized in the nucleus but marginated. Some neurons had morphologic abnormali-
ties that were not severe enough to be considered evi-not in the cytoplasm (Figure 5I). Almost all of these were
too small to have been visualized by light microscopy dence of cell death but manifested mild hyperchromasia
and a more oval cellular shape (Figure 7D).and were thus termed microaggregates. With the same
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Electron microscopy using the same tissue blocks con- months, YAC72 mice had an initial increase in the NMDA
component of synaptic response, which was antago-firmed the degenerative and abnormal nature of these
nized by D-AP5, an NMDA receptor antagonist. This ismorphologic changes. By electron microscopy, degen-
consistent with the NMDA receptor hyperactivity associ-erative changes varied in severity and included reduced
ated with the presence of mutant htt. In animals, over-neuronal size, the presence of nuclear and plasma mem-
activation of NMDA receptors in the striatum has beenbrane irregularities, increased electron density of the
shown to reproduce biochemical and neuropathologicalcytoplasm and the nucleus, swelling of some mitochon-
changes seen in HD (Ferrante et al., 1985; Beal et al.,dria, dilation of Golgi cisternae, nuclear shrinkage and
1989). Recent in vitro data also reveal that mutant httcondensation, and margination of heterochromatin (Fig-
increases the size of currents through the NMDA recep-ures 6D, 6E, and 7E). These degenerative features are
tor subtypes, which are preferentially expressed in theconsistent with apoptosis. In addition to frank degenera-
medium spiny neostriatal neurons (Chen et al., 1999).tion, electron microscopy also revealed frequent irregu-
These data represent in vivo evidence in favor of NMDAlar nuclear envelopes in neurons (Figure 6F).
receptor hyperactivity as an early abnormality in theSignificant degeneration was present in the striatum
pathogenesis of HD, consistent with the hypothesis ofof the YAC72 2498 mouse and in the YAC72 2511 line
excitotoxicity in HD (Albin and Greenamyre, 1992; Coyleat 12 months. No degeneration was found in the YAC46
and Puttfarchen, 1993).or YAC18 (Figure 6C) or in wild-type controls. In the
An increase in NMDA receptor function would give risestriatum of mouse 2498, there was extensive neuronal
to an elevated influx of calcium during normal synapticdegeneration, most severe laterally, decreasing in a
transmission. Our studies indicated higher resting levelsgraded fashion more medially (Figures 6A and 6B). The
of calcium in neurons from mutant mice at 10 monthsproportion of degenerating neurons ranged from 4% of
of age. Increases in intracellular calcium levels are asso-observable neurons medially to 80% of neurons laterally.
ciated with calcium-dependent desensitization of bothIn the striatum of 12-month-old low-expressing YAC72
voltage- and ligand-gated channels, including NMDAmice (2511), numerous degenerating neurons (Figure
receptors. It is therefore possible that during high-fre-7D) were present. As in 2498, degenerating neurons
quency stimulation, NMDA receptors are inactivatedwere most frequent in the lateral striatum. The medial-
due to high-calcium influx, which could underlie the lackto-lateral gradient of neurodegeneration was less dra-
of LTP in those mice with mutant htt. In both YAC46matic than in the 2498 mouse, ranging from 4% medially
and YAC72 mice, the electrophysiological abnormalitiesto z40% laterally. We found no sign of degeneration
precede any obvious behavioral abnormalities as wellin the YAC72 2511 line at 8 months of age. There was
as any evidence of neurodegeneration or aggregate for-no evidence of reactive gliosis in these mice by glial
mation. Taken together, these results suggest that ex-fibrillary acidic protein immunocytochemistry (data not
pression of mutant htt in these mice causes cytoplasmicshown).
dysfunction before the observed behavioral and neuro-The hippocampus was examined, since YAC transgenic
pathologic changes.mice had abnormal hippocampal LTP, and neuronal loss
Examination of N terminus htt fragment aggregationin the CA1 region of the hippocampus is seen in most
in the YAC72 2498 and YAC72 2511 lines does not sup-patients with HD (Spargo et al., 1993). Examination of
port the hypothesis that large nuclear aggregates under-semithin and Nissl-stained sections (50 mm) from wild-
lie neurodegeneration. In the YAC72 2498 mouse, whichtype, YAC18, and YAC46 mice at ages 5, 9, 12, and 20
expressed high levels of mutant htt and had an obviousmonths showed no obvious differences in the gross
behavioral phenotype by 6 weeks of age, 80% of theorganization and neuronal density of the CA1 pyramidal
neurons still observable in the lateral striatum at 1 yearcell layer and no increase in the presence of degenerat-
of age were undergoing neurodegeneration. In both de-ing neurons.
generating and normal-appearing neurons, N-terminal
nuclear htt fragments were labeled with solitary and
Discussion small clusters of immunogold particles, and only rarely
were macroaggregates observed. Furthermore, the com-
We have produced YAC transgenic mice that express plete absence of macroaggregates and the rarity of mi-
normal and mutant htt in a developmentally regulated croaggregates in the normal and degenerating striatal
and cell-specific pattern identical to that of endogenous neurons in the YAC72 2511 line at 12 months of age
htt and develop functional, behavioral, and pathological suggest that even microaggregates may not be neces-
changes similar to those of patients with HD. This is sary for cell death. The immunogold method, however,
manifest with selective neurodegeneration affecting does not permit distinguishing solitary N terminus frag-
specifically the medium spiny neurons of the striatum. ments from the smallest possible multimers.
Furthermore, we show that neurodegeneration can oc- In vitro evidence has suggested that proteolytic cleav-
cur in the absence of aggregates, providing evidence age of htt plays an important role in the pathogenesis
that aggregates are not essential for the initiation of the of htt (Hackam et al., 1998, 1999; Martindale et al., 1998).
illness. The studies in the YAC transgenic mice now provide direct
YAC transgenic mice expressing mutant htt with 46 evidence of cleavage of htt by demonstration of N-termi-
CAG repeats do not have a clinical phenotype by de- nal fragments in the nucleus and C-terminal fragments
tailed behavioral analysis for up to 20 months of age. in the cytoplasm. Furthermore, immunogold-labeled elec-
However, electrophysiological abnormalities are evident tron microscopy has revealed gold-labeled htt frag-
much earlier. The severity of electrophysiological abnor- ments traversing the nuclear pore to the nucleus from
malities is more obvious in mice with 72 compared with the cytosol. Importantly, the N-terminal translocation of
htt appears to be only evident in those neurons that are46 CAG repeats at the same age. Interestingly, at 6
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repeats, was linearized with BstEII and transformed into yeast sphe-susceptible to subsequent neurodegeneration, namely,
roplasts. The region of DNA containing the expanded CAG repeatthe medium spiny neurons. The striatal interneurons,
plus sufficient flanking homologous DNA (EE640) was cloned intowhich are largely spared in HD, did not show presence
the pRS406 vector. The EE640 fragment, containing 48 CAG repeats,
of htt in the nucleus. This suggests that one reason was cloned from the L191F1 cosmid containing an expanded CAG
for selective neuronal degeneration in HD might be the repeat. This same fragment, containing 72 repeats, was shotgun
cloned from patient DNA. These clones were transformed into yeast,generation of proteolytic cleavage of htt in specific cells,
and pop-in and pop-out clones were selected as described pre-with resultant N-terminal translocation of htt into the
viously (Duff et al., 1994).nucleus specifically in those cells.
The increased intracellular calcium concentration
Generation and Screening of YAC Transgenic Miceseen in the YAC46 mice at 10 months of age, prior to any
YAC DNA was prepared for microinjection into FVB/N pronuclei,evidence of nuclear translocation of htt or apoptosis,
and founder pups were screened (Hodgson et al., 1996). Furthersupports a model in which the initial trigger for the illness
analysis of the 59 region of YAC YGA2 was done by Southern analysis
is cytoplasmic toxicity, which is associated with in- using the probes OS14, D4S95, and OT17, a gift from Dr. S. Hadano.
creased cytoplasmic calcium concentration. These find-
ings are highly reminiscent of the recent reports in early
Protein Expression Analysis
onset familial Alzheimer's disease, whereby activation Bone marrow fibroblast cultures were established from YAC72
of caspases by mutant presenilin 1 is preceded by an founders 2498 and 2511 and an age-matched FVB/N mouse in Dul-
elevation in cytoplasmic calcium (Buxbaum et al., 1998). becco's modified Eagle's medium, 10% fetal calf serum, penicillin/
streptomycin, and 20 mM L-glutamine (Canadian Life Technologies).Altered concentrations of cytoplasmic calcium may be
Cells were maintained at a humidified atmosphere of 378C, 6% CO2.an important trigger for activation of the proteolytic
For the isolation of proteins, cells were lysed in buffer (1.0% NP40,pathways, leading to the generation of truncated frag-
0.15 M NaCl, 50 mM Tris [pH 8.0], and 0.01% azide). Protein (100
ments for both Alzheimer's disease and HD (Kim and
mg) was resolved in 7.5% SDS±PAGE minigels. Membranes were
Tanzi, 1998). reacted with the anti-htt monoclonal antibody GHM1 (Kalchman et
Recently, there have been reports of other transgenic al., 1997) or an anti-actin monoclonal antibody (Sigma) by standard
conditions.mice expressing different portions of htt (Mangiarini et
al., 1996; White et al., 1997; Reddy et al., 1998; Schilling
et al., 1999) under the control of varying promoters. Behavioral Analysis
Mice were handled and checked on a weekly basis. For a moreThese mice display a significant neurological phenotype
qualitative assessment, YAC46, YAC18, and control mice were vid-associated with the development of intranuclear aggre-
eotaped for 2 hr in a fresh cage identical to the one in which theygates and in some cases, neurodegeneration, but as yet,
were housed every 2 months from 8 to 20 months of age. For a 10no evidence of the selective striatal neurodegeneration
s interval every minute, the behavior of the subjects was recorded;
seen in HD. This suggests that expression of full-length the frequency of such behaviors as inactivity, grooming, scratching,
htt and/or expression in a cell-specific and develop- sniffing, gnawing, burying, rearing, locomotion, climbing, circling,
jumping, and mounting was noted. YAC72 mice (line 2511) weremental manner, as seen with its own promoter, may
assessed at 3, 7, and 9 months, while YAC72 mouse 2498 wasbe important for accurately recapitulating the disease
assessed every 2 months from 3 to 12 months of age.phenotype.
Motor control was tested by the ability to climb a wire screenA major question still left unanswered is, what is the
secured against the wall at a 608 angle and was observed until they
nature of the initial toxic stimulus in the cytoplasm that reached the top or bottom. For coordination, mice were placed
initiates the cell death pathways, leading to neurodegen- midway on a suspended beam and observed for latency of initiative
movement, number of falls, and time to reach safety. Mice wereeration? One possibility is that there may be disturbed
assessed for abnormal righting or posturing by suspension by theinteraction with an interacting protein such as HAP1 (Li
tail. Spontaneous motor activity was measured with photo beamset al., 1995) or HIP1 (Kalchman et al., 1997; Wanker
in a novel test chamber during 2 hr of light and 2 hr of dark aset al., 1997), which then induces cellular toxicity and
described previously (Nasir et al., 1995).
promotes the proteolytic processing of htt. Electrophysiology
These YAC transgenic mice represent the first animal Hippocampal slices (400 mm thick) from 6- and 10-month-old sex-
matched mice were obtained as described previously (Dingledine,model with mutant full-length htt expressed under the
1984) and perfused in an interface chamber at 328C with oxygenatedcontrol of its endogenous promoter, with all intronic
artificial cerebrospinal fluid (ACSF) containing (in mM): NaCl, 124;regulatory sequences included. This developmentally
KCl, 3.0; KH2PO4, 1.25; CaCl2, 4.0; NAHCO3, 26.0; and D-glucose,appropriate expression of mutant htt in the appropriate
10 and 10 mm bicucculline methiodide (GMI; Sigma Chemical). In
cellular compartments has produced animals with be- selected slices, 25 mM D-AP5 (Tocris) was added to the perfusate
havioral, electrophysiological, and pathological pheno- to block NMDA receptors. To invoke tetanus, LTP consisted of five
trains of 100 Hz stimulations lasting 200 ms at an intertrain intervaltypes occurring at different stages of development, giv-
of 10 s. A control pathway, which did not receive pattern stimulation,ing insights into the sequence of cellular and molecular
was also monitored to determine the general state of the slice. Slicesevents underlying the pathogenesis of HD. In particular,
that demonstrated either an increase or decrease in the fEPSP slopethe YAC72 line, with selective striatal neurodegeneration
evoked by the stimulation of the control pathway following HFS of
by 1 year of age, allows therapeutic strategies to be the test pathway were omitted from data analysis.
assessed that delay or prevent HD. Data are expressed as mean 6 SEM, n 5 number of animals.
Significance was tested by the Student's t test. Experiments were
done double blind.
Calcium MeasurementsExperimental Procedures
Punched cultures of CA1 neurons were dissociated as described
previously (Cohen and Wilkin, 1995). Cells were loaded with 5 mMYAC Mutagenesis
YAC mutagenesis was performed as described previously (Duff et Fura2-AM (Molecular Probes) by incubating them for 45 min at room
temperature in ACSF containing (in mM): NaCl, 140; KCl, 5; MgCl2,al., 1994). The pop-in construct (see text), containing 46 or 72 CAG
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1; CaCl2, 2; and HEPES, 10 (buffered to pH 7.3 with NaOH). Fluores- X. J. L.). Dr. Michael Hayden is an established investigator of the
British Columbia Children's Hospital.cence measurements were conducted by the use of a PTI D104F
series microscope (Nikon Diaphot 200) and a 403 oil immersion
objective at room temperature. Cell densities were one to five cells Received March 8, 1999; revised April 12, 1999.
per field. Baseline (30 s) measurements were obtained prior to gluta-
mate (10±100 mM) application. Digitonin (20 mM) was added at the
Referencesend of the experiment to record background fluorescence. Ratio
measurements were converted into estimates of [Ca21]i according
Albin, R.L., and Greenamyre, J.T. (1992). Alternative excitotoxic hy-to the Grynkiewicz equation (Grynkiewicz et al., 1985). Kd, Rmin, Rmax,
pothesis. Neurology 42, 733±738.Fb380, and Ff380 values were determined with a calcium calibration
kit containing Mg21 (Molecular Probes) and were rechecked every Beal, M.F., Lowall, N.W., Swartz, K.J., Ferrante, R.J., and Martin,
week. Estimated values were Kd, 227 6 5 nM; Rmin, 0.44; and Rmax, 5.7. J.B. (1989). Differential sparing of somatostain-neuropeptide Y and
cholinergic neurons following striatal excitotoxin lesions. Synapse
3, 38±47.
Antibodies
Becher, M.W., Rubinsztein, D.C., Leggo, J., Wagster, M.V., Stine,Four antibodies against various regions of htt were used: a rabbit
O.C., Ranen, N.G., Franz, M.L., Abbott, M.H., Sherr, M., MacMillan, etpolyclonal antibody (EM48) to amino acids 1±256 (Gutekunst et al.,
al. (1997). Dentatorubral and pallidoluysian atrophy (DRPLA). Clinical1999), a rabbit polyclonal antibody (HD-N) to the first 17 amino acids
and neuropathological findings in genetically confirmed North Amer-of human htt (provided by Peter Detloff), a rat monoclonal antibody
ican and European pedigrees. Mov. Disord. 12, 519±530.(HD549) to amino acids 549±679 (Gutekunst et al., 1995), and a
Buxbaum, J.D., Choi, E.K., Luo, Y., Lilliehook, C., Crowley, A.C.,monoclonal antibody (GHMI) directed to the internal region of htt
Merriam, D.E., and Wasco, W. (1998). Calsenilin: a calcium-binding(Hodgson et al., 1996). Other antibodies were directed against the
protein that interacts with the presenilins and regulates the levelsVAT, which labels cholinergic interneurons; NOSI (Chemicon Inter-
of a presenilin fragment. Nat. Med. 4, 1177±1181.national, Temecula, CA), which labels neurons containing somato-
statin, neuropeptide Y, and NADPH-diaphorase activity; and PARV Chen, N., Luo, T., Wellington, C., Metzler, M., McCutcheon, K., Hay-
(Sigma, St. Louis, MO), which labels another distinct population of den, M.R., and Raymond, L.A. (1999). Subtype-specific enhance-
medium-sized interneurons. ment of NMDA receptor currents by mutant huntingtin. J. Neuro-
chem. 72, 1820±1898.
Cohen, J., and Wilkin, G.P. (1995). Neural Cell Culture (New York:Light and Electron Microscopic Immunocytochemistry
Oxford University Press).Each mouse was anesthetized with sodium pentobarbitol, injected
Cooper, J.K., Schilling, G., Peters, M.F., Herring, W.J., Sharp, A.H.,intraperitoneally with 300 IU of heparin, and perfused intracardially
Kaminsky, Z., Masone, J., Khan, F.A., Delanoy, M., Borchelt, D.R.,with 200 ml of 3% paraformaldehyde and 0.15% glutaraldehyde in
et al. (1998). Truncated N-terminal fragments of huntingtin with ex-0.1 M phosphate buffer (PB) at pH 7.2. Brains were removed and
panded glutamine repeats form nuclear and cytoplasmic aggregatespostfixed overnight in 2% paraformaldehyde. Brains were sectioned
in cell culture. Hum. Mol. Genet. 7, 783±790.in ten series of 40 mm coronal sections with a vibratome (Pelco,
Redding, CA), collected in PB, and rinsed in 0.05 M phosphate- Coyle, J.T., and Puttfarchen, P. (1993). Oxidative stress, glutamate,
buffered saline (PBS [pH 7.2]). Light and electron microscopy immu- and neurodegenerative diseases. Ann. Neurol. 38, 357±366.
nocytochemistry were performed as described previously (Gute- Davies, S.W., Turmaine, M., Cozens, B.A., DiFiglia, M., Sharp, A.H.,
kunst et al., 1995, 1999). Ross, C.A., Scherzinger, E., Wanker, E.E., Mangiarini, L., and Bates,
For double immunolabeling experiments, EM48 antibody was G.P. (1997). Formation of neuronal intranuclear inclusions (NII) un-
combined with either VAT, NOSI, or PARV antibody in the primary derlies the neurological dysfunction in mice transgenic for the HD
incubation. Controls included the omission of primary antisera and mutation. Cell 90, 537±548.
single labeling for each antibody.
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young,
C., Martin, E., Vonsattel, J.P., Carraway, R., Reeves, S.A., et al.
(1995). Huntingtin is a cytoplasmic protein associated with vesiclesAssessment of Neurodegeneration
in human and rat brain neurons. Neuron 14, 1075±1081.Neurodegeneration was assessed in semithin sections (1.5 mm) from
striatum, cortex, hippocampus, and cerebellum in all lines. Sections DiFiglia, M., Sapp, E., Chase, K.O., Davies, S.W., Bates, G.P., Vonsat-
were cut with a Leica Ultracut S ultramicrotome, counterstained tel, J.P., and Aronin, N. (1997). Aggregation of huntingtin in neuronal
with toluidine blue, differentiated in 95% alcohol, and coverslipped. intranuclear inclusions and dystrophic neurites in brain. Science
Neuronal degeneration was quantified as follows: sections were 277, 1990±1993.
visualized on a Nikon Labophot-2 microscope with a 603 lens Dingledine, R. (1984). Brain Slices (New York: Plenum Press).
equipped with a 1 mm2 ocular grid. A starting frame was systemati-
Duff, K., McGuigan, A., Huxley, C., Schulz, F., and Hardy, J. (1994).cally selected so that one side of the ocular grid was touching the
Insertion of a pathogenic mutation into a yeast artificial chromosomemost lateral portion of the corpus callosum. From this starting point,
containing the human amyloid precursor protein gene. Gene Ther.counts were made with three 240 mm2 frames obtained by moving
1, 70±75.the grid toward the medial portion of the striatum, one grid length
Duyao, M.P., Auerbach, A.B., Ryan, A., Persichetti, F., Barnes, G.T.,at a time. This was repeated in each section. Within each frame, all
McNeil, S.M., Ge, P., Vonsattel, J.-P., Gusella, J.F., Joyner, A.L., andneurons with visible nuclei were counted and categorized as normal
MacDonald, M.E. (1995). Inactivation of the mouse Huntington'sor degenerating. In each counting frame, the top and right frame
disease gene homolog Hdh. Science 269, 407±410.lines were excluded from analysis.
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